Evidence map›Paper›PMID 33168066›Full record

ArticleJournal of ethnobiology and ethnomedicine2020

"Peruvian balsam": an example of transoceanic transfer of medicinal knowledge.

Angela Schottenhammer

Abstract readHistorical Article
In one paragraph

Article in Journal of ethnobiology and ethnomedicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Angela SchottenhammerHistory Department, Faculty of Arts, KU Leuven, Blijde Inkomststraat 21 - bus, 3307, 3000, Leuven, Belgium. Angela.Schottenhammer@kuleuven.be.ORCID http://orcid.org/0000-0002-0952-7621

Funding

H2020 European Research Council (ERC AdG) No. 833143
6 · The paper itself

Abstract

backgroundConnections between China and the new Spanish colonies in America are known for an exchange of silver for silks and porcelains. That also medicinal drugs and medicinal knowledge crossed the Pacific Ocean is hardly known or discussed. Myroxylon balsamum (L.) Harms var. pereirae (Royle) Harms ("New World" or "Peruvian balsam") is a botanical balsam that has a long history of medicinal use, particularly as antiseptic and for wound healing. Except for a Chinese article discussing the reception of balsam in China and Japan, no scientific studies on its impact in China and Japan and the channels of transfer from the Americas to Asia exist.

methodsDescription: (1) This section provides a general introduction into Commiphora gileadensis ("Old World" balsam) as a medicinal category and discusses the specific medicinal properties of Myroxylon balsamum (L.) Harms var. pereirae (Royle) Harms. The section "Historical research and uses" provides a brief survey on some historical analyses of balsam. Aim, design, setting: (2) Applying a comparative textual and archaeological analysis the article critically examines Chinese and Japanese sources (texts, maps) to show (i) what Chinese and Japanese scholars knew about balsam, (ii) where and how it was used, and (iii) to identify reasons why the "digestion" of knowledge on balsam as a medicinal developed so differently in China and Japan. RESULTS AND DISCUSSION: This chapter discusses the introduction of "Peruvian balsam" into, its uses as a medicinal as well as its scholarly reception in early modern China and Japan and introduces the channels of transmission from Spanish America to Asia. It is shown that Myroxylon balsamum (L.) Harms var. pereirae (Royle) Harms was partly a highly valued substance imported from the Americas into China and Japan. But the history of the reception of medicinal knowledge on Peruvian balsam was significantly different in China and Japan.

conclusionsIn Japan, the knowledge on Myroxylon balsamum was continuously updated, especially through mediation of Dutch physicians; Japanese scholars, doctors and pharmacists possessed a solid knowledge on this balsam, its origin and its medicinal uses. In China, on the contrary, there was no further "digestion" or development of the knowledge on either Myroxylon balsamum (L.) Harms var. pereirae (Royle) Harms or Commiphora gileadensis. By the late nineteenth century, related medicinal and even geographic knowledge had mostly been lost. The interest in "balsam" in late Qing scholarship was pure encyclopaedic and philosophic.

Indexed as

BalsamsCommiphoraKnowledgeMyroxylonPlants, MedicinalArchaeologyChinaHistory, 16th CenturyHistory, 17th CenturyHistory, 18th CenturyHumansInformation DisseminationJapanSouth AmericaBalsamsPeruvian balsamChinaColonial Spanish AmericaDrug tradeGlobal history of medicineJapanMaritime historyMedicinal plantsPeruvian balsam

Identifiers

PMID33168066
PMCPMC7650155

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.